Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes

Por Cuccia F, Mortellaro G, Serretta V, Valenti V, Tripoli A, Gueci M, Luca N, Lo Casto A, Ferrera G
Publicado em 2018-10-01

Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate can...

Por Albrecht, W, Van Poppel, H, Horenblas, S, Mickisch, G, Horwich, A, Serretta, V, Casetta, G, Maréchal, J M, Jones, W G, Kalman, S, Sylvester, R
Publicado em 2004

The efficacy of BCG Tice and BCG Connaught in a cohort of 2099 T1G3 non-muscle invasive bladder cancer patients

Por Witjes, JA, Dalbagni, G, Karnes, J, Shariat, S, Joniau, S, Palou, J, Serretta, V, Larré, S, di Stasi, S, Colombo, R, Babjuk, M, Malmström, PU, Malats, N, Irani, J, Baniel, J, Cai, T, Cha, E, Ardelt, P, Varkarakis, J, Bartoletti, R, Spahn, M, Pisano, F, Gontero, P, Sylvester, R
Publicado no Urol Oncol (2016)

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy

Por Soria, Francesco, Pisano, Francesca, Gontero, Paolo, Palou, J, Joniau, S, Serretta, V, Larré, S, Di Stasi, S, van Rhijn, B, Witjes, A, Grotenhuis, A, Colombo, R, Briganti, A, Babjuk, M, Soukup, V, Malmstrom, PU, Irani, J, Malats, N, Baniel, J, Mano, R, Cai, T, Cha, E, ardelt, P, Varkarakis, J, Bartoletti, R, Dalbagni, G, Shariat, SF, Xylinas, E, Karnes, RJ, Sylvester, R
Publicado no World J Urol (2018)